HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Unique AI-Based Counting System Advances Accuracy and Throughput for COVID-19 Vaccine

By HospiMedica International staff writers
Posted on 23 Oct 2020
Image: COUNTQ(TM) system (Photo courtesy of Verista)
Image: COUNTQ(TM) system (Photo courtesy of Verista)
A new inspection and reconciliation machine is helping pharmaceutical companies accelerate COVID-19 vaccines from development to manufacturing with accelerated technology transfer.

The COUNTQ system from Verista (Fishers, IN, USA) is an inspection and reconciliation machine used to accurately count tray-loaded parts, including vaccine vials. The machine significantly increases accuracy of count and throughput versus manual methods. Pharmaceutical companies must account for all vaccine vials on a production line, and the process includes inspection, labeling, re-inspection, boxing and shipping. With the COUNTQ system, a trained operator can accurately inspect a tray in 15 seconds. The machines eliminate count deviations that occur during the filling, inspection and packaging processes. The system's software provides 100% electronic verification of product counts and eliminates the reworking of vaccine lots due to reconciliation and count discrepancies.

A single COUNTQ machine handles vials, syringes, ampoules and other tray-loaded parts. The COUNTQ systems offer deep learning (form of AI) to enable the inspection of products that cannot be counted consistently with traditional machine vision technologies. COUNTQ machines offer deep learning for scenarios in which there is greater variation in products and presentation to the camera, such as the inspection of ampoules. The stainless-steel COUNTQ systems are available in multiple forms for different manufacturing environments, including full-sized units with conveyor transport and smaller manual feed and inline options. The machines are portable and can move along the manufacturing process.

"How quickly COVID-19 vaccine production ramps up will depend on technology like COUNTQ for vial count verification and reconciliation," said Jim Evans, Director, Vision, Connectivity & Automation Division, Verista. "Normally it takes years to adapt manufacturing processes for millions or billions of vaccine doses. The rapid scale-up of COVID-19 vaccine production involves a complex production process, strict quality standards and the right regulatory registrations. The COUNTQ system provides vaccine manufacturers increased efficiency and count accuracy, while reducing operational costs. Our unique AI-based counting system works with an operator to verify everything on a tray of vials is accounted for and correct."

Related Links:
Verista

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Radiation Safety Barrier
RayShield Intensi-Barrier

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more